1. Assessing Clinical Factors Influencing Deep Learning Performance in Organ Segmentation on Gadoxetic acid enhanced MRI: A Retrospective Study of Chronic Liver Disease Patients
2. Assessing Hepatic Metabolism in Patients with HCC Using 31P-MRS: Insights and Potential Clinical Utility
3. Multi-Channel Fluorescence Sensor Array for Protein Discrimination and its Application in Hepatocellular Carcinoma Diagnosis
4. Tailored Surveillance intervals of ultrasonography for detection of early stage hepatocellular carcinoma: Nationwide population based study in Korea
5. Age difference in the association of alcohol consumption and the risk of hepatocellular carcinoma: A nationwide cohort study
6. Fibrolamellar Carcinoma Registry: Opportunities and Challenges
7. Frequent AFP Testing Enhances Survival Rates in Hepatitis B-Associated Hepatocellular Carcinoma
10. A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy
11. Changes in liver stiffness and controlled attenuation parameters of transient elastography according to weight change in non-alcoholic fatty liver disease
12. Development of a novel prognostic score for intrahepatic cholangiocarcinoma based on tumor size and number of tumor
13. Heavy Smoking Increases Early Mortality Risk in Patients with Hepatocellular Carcinoma after Curative Treatment
14. Predictors of Normal Alpha-Feto Protein among Patients Who Underwent Surveillance for Hepatocellular Carcinoma
15. Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
16. A Comparative Analysis of RECIST 1.1 and mRECIST in Assessing Tumor Response to FOLFOX Regimen of Hepatocellular Carcinoma: Thailand Experience
19. Comparison of Transarterial Chemoembolization vs Radioembolization for Large Unresectable Hepatocellular Carcinoma (> 8 cm): A Propensity Score Matching Analysis
20. First interim outcomes analysis of an investigator-initiated clinical trial evaluating liquid biopsy and PET-based predictive biomarkers for advanced unresectable hepatocellular carcinoma
22. Immunoscore Predicted by Dynamic Contrast-enhanced Computed Tomography Can be a Non-invasive Biomarker for Immunotherapy of Hepatocellular Carcinoma
27. Predictive Imaging Features of Bile Duct Invasion in Hepatocellular Carcinoma on MRI with Hepatobiliary Contrast Agents
29. Radiomics for Survival Risk Stratification of Multinodular Hepatocellular Carcinoma Patients Beyond the Milan Criteria
30. Real-world Application of Noncontrast-Abbreviated Magnetic Resonance Imaging in Hepatocellular Carcinoma Surveillance
33. Diagnostic value of carbohydrate antigen 50 in biliary tract cancer: A large-scale multicenter study
38. Efficacy and safety of ablative radiotherapy for patients with primary liver cancers with massive inferior vena cava and cardiac extension
40. Feasibility Study of Combined Chemotherapy and Carbon-ion Radiotherapy for Hepatocellular Carcinoma Patients
42. Long-term outcome of a multicenter prospective study on efficacy and safety of high-dose Stereotactic Body Radiation Therapy ≥ 48 hour-interfraction interval for ≤ 5 cm hepatocellular carcinoma
43. Preliminary Results of Sequential Transarterial Chemoembolization, Stereotactic Body Radiotherapy Followed by STRIDE in Unresectable Hepatocellular Carcinoma: Single-Arm Phase II Trial
44. Radiotherapy for extrahepatic intraabdominal metastases from hepatocellular carcinoma
45. The Clinical Utilization of Radiotherapy for Liver and Gallbladder/Biliary Cancer in Republic of Korea between 2009 and 2020
47. Survival Benefit of Resectability Determined by Multiple Surgeons in BCLC-C Stage: A Single-Center Cohort Study
121. Single-cell RNA sequencing reveals pro-inflammatory macrophages are essential for immune activation in hepatocellular carcinoma patients treated with immune
167. Surgical strategy for incidental intrahepatic cholangiocarcinoma in terms of lymph node dissection
183. Korean multicenter Prospective observational study on efficacy of Y90 for HCC (KURE-YTT-HCC): interim results